EZH2 and diffuse large B-cell lymphoma: However, the upregulation of insulin-like growth factor1 receptor (IGF-1R), mitogen-activated protein kinase kinase (MEK), or phosphoinositide 3-kinase (PI3K) pathways was observed in diffuse large B-cell lymphomas after EZH2 inhibition.